A detailed history of California State Teachers Retirement System transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 87,042 shares of NTLA stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,042
Previous 89,851 3.13%
Holding current value
$1.16 Million
Previous $2.01 Million 11.04%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.72 - $27.36 $55,393 - $76,854
-2,809 Reduced 3.13%
87,042 $1.79 Million
Q2 2024

Aug 14, 2024

BUY
$20.02 - $27.22 $86,486 - $117,590
4,320 Added 5.05%
89,851 $2.01 Million
Q1 2024

May 15, 2024

SELL
$23.82 - $32.8 $92,159 - $126,903
-3,869 Reduced 4.33%
85,531 $2.35 Million
Q4 2023

Feb 13, 2024

SELL
$23.16 - $32.34 $4,933 - $6,888
-213 Reduced 0.24%
89,400 $2.73 Million
Q3 2023

Nov 14, 2023

SELL
$31.62 - $45.78 $298,524 - $432,208
-9,441 Reduced 9.53%
89,613 $2.83 Million
Q2 2023

Aug 21, 2023

BUY
$34.58 - $46.03 $207,480 - $276,180
6,000 Added 6.45%
99,054 $4.04 Million
Q1 2023

May 09, 2023

SELL
$33.3 - $44.82 $13,353 - $17,972
-401 Reduced 0.43%
93,054 $3.47 Million
Q4 2022

Feb 14, 2023

BUY
$33.21 - $62.69 $163,824 - $309,249
4,933 Added 5.57%
93,455 $3.26 Million
Q3 2022

Nov 18, 2022

SELL
$53.92 - $71.7 $45,184 - $60,084
-838 Reduced 0.94%
88,522 $4.95 Million
Q2 2022

Aug 15, 2022

BUY
$38.49 - $76.21 $91,875 - $181,913
2,387 Added 2.74%
89,360 $4.63 Million
Q1 2022

May 16, 2022

SELL
$58.27 - $118.99 $406,025 - $829,122
-6,968 Reduced 7.42%
86,973 $6.32 Million
Q4 2021

Feb 15, 2022

BUY
$100.76 - $138.36 $655,443 - $900,031
6,505 Added 7.44%
93,941 $11.1 Million
Q3 2021

Nov 15, 2021

SELL
$132.37 - $176.78 $80,480 - $107,482
-608 Reduced 0.69%
87,436 $11.7 Million
Q2 2021

Aug 16, 2021

BUY
$60.88 - $161.91 $322,542 - $857,799
5,298 Added 6.4%
88,044 $14.3 Million
Q1 2021

May 18, 2021

BUY
$46.59 - $83.68 $322,030 - $578,396
6,912 Added 9.11%
82,746 $6.64 Million
Q3 2020

Nov 17, 2020

BUY
$17.47 - $24.93 $170,315 - $243,042
9,749 Added 14.75%
75,834 $1.51 Million
Q2 2020

Aug 17, 2020

BUY
$11.14 - $22.87 $85,700 - $175,938
7,693 Added 13.17%
66,085 $1.39 Million
Q1 2020

May 13, 2020

SELL
$9.44 - $15.58 $17,482 - $28,854
-1,852 Reduced 3.07%
58,392 $714,000
Q3 2019

Nov 15, 2019

BUY
$13.07 - $18.51 $54,802 - $77,612
4,193 Added 7.48%
60,244 $804,000
Q2 2019

Aug 14, 2019

BUY
$13.88 - $18.41 $71,898 - $95,363
5,180 Added 10.18%
56,051 $918,000
Q1 2019

May 09, 2019

SELL
$12.79 - $17.62 $14,925 - $20,562
-1,167 Reduced 2.24%
50,871 $869,000
Q4 2018

Feb 13, 2019

BUY
$11.39 - $27.13 $13,770 - $32,800
1,209 Added 2.38%
52,038 $710,000
Q3 2018

Nov 14, 2018

SELL
$25.78 - $32.6 $464 - $586
-18 Reduced 0.04%
50,829 $1.46 Million
Q2 2018

Aug 14, 2018

BUY
$20.02 - $30.79 $512,051 - $787,515
25,577 Added 101.21%
50,847 $1.39 Million
Q1 2018

May 15, 2018

SELL
$19.43 - $34.95 $19,468 - $35,019
-1,002 Reduced 3.81%
25,270 $533,000
Q4 2017

Feb 14, 2018

BUY
$17.39 - $31.12 $50,935 - $91,150
2,929 Added 12.55%
26,272 $505,000
Q3 2017

Nov 13, 2017

BUY
$15.16 - $25.75 $353,879 - $601,082
23,343
23,343 $580,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.02B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.